BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) announced positive results in a Phase II study of the Pill-Plus "triple hormone" oral contraceptive (OC). Results showed an increase in the frequency of sexual activity (pThe study was a Phase II double-blind randomized clinical trial in 82 women...